Press Releases
LOS ANGELES, May 06, 2024 (GLOBE NEWSWIRE) -- Hanmi Financial Corporation (NASDAQ: HAFC, or “Hanmi”), the parent company of Hanmi Bank (the “Bank”), today announced its participation in the D.A. Davidson 26th Annual Financial Institutions Conference on Thursday, May 9, 2024, in Colorado Springs, CO.
Bonnie Lee, President and Chief Executive Officer, and other members of the executive team will host one-on-one and small group meetings throughout the day.
The Total Shares Held or Secured Through Purchase Agreements Now Represents 59% of the Shares Outstanding in Fortress Insurance and Exceeds the 51% Minimum Required to Complete the Transaction
Western Continues to Work Towards Securing the Maximum Number of Shares Possible in Fortress Insurance Through Additional Share Purchases
CALGARY, Alberta, May 06, 2024 (GLOBE NEWSWIRE) -- The Western Investment Company of Canada Limited (TSXV: WI) ("Western" or the... (continue reading...)
- 2023 Revenue of $4.9m in 2023
- Technological innovations elevate product offering including AI Virtual Concierge and SAAS based platform
- Growth of global Channel Partners expected to scale revenue in 2024 and beyond
- Q1 2024 revenue of approximately $1.6m
TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- ARHT Media Inc. ("ARHT" or "the Company") (TSXV: ART), (OTCQB: ARHTF) the global leader in the development, production and distribution of high-quality, low latency hologram... (continue reading...)
LAS VEGAS, May 06, 2024 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (NASDAQ: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, will issue its financial results for its fiscal second quarter ended March 31, 2024, before market open on Monday, May 13, 2024. The Company will hold a conference call to discuss the results on Monday, May 13, 2024, at 2:00 p.m. Pacific Daylight Time (5:00 p.m. Eastern Daylight Time).
The dial-in numbers are... (continue reading...)
- Both drugs demonstrated 50% response for treating depression. NRX-101 demonstrated a mean 76% reduction in symptoms of akathisia compared to lurasidone that was sustained over 42 days (Effect Size .37; P=0.025), using prespecified analytic methodology memorialized in FDA Special Protocol Agreement. Levels of akathisia with NRX-101 were essentially zero at day 42
- This safety advantage was previously reported in the Company's published STABIL-B trial
- Akathisia is... (continue reading...)
More Press Releases
View Older Stories-
Cybeats Unveils New Product at RSAC 2024; The First-Ever 'BCA Marketplace' Offers a Hub for Leading Cybersecurity Solutions
-
NaaS Technology Inc. to Report 2024 First Quarter Unaudited Financial Results on May 9, 2024 Eastern Time
-
The TurfMutt Foundation Shares 5 Reasons We Need More Yards, Parks and Community Green Space
-
ESQUIRE FINANCIAL HOLDINGS, INC. INCLUDED IN KBW'S 2024 HONOR ROLL
-
TuSimple Appoints Two New Directors to its Board of Directors
-
Alexandria Real Estate Equities, Inc. Drives Forward Its Action- and Solutions-Oriented Corporate Responsibility Initiatives Aimed at Prioritizing the Staggering Mental Health Crisis During Mental Hea
-
CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024
-
Xcitium's Pre-Emptive Cybersecurity Platform Brings the Power of the AI PC to its customers with Integration of Intel® Threat Detection Technology (Intel® TDT)
-
Neurocrine Biosciences Supports Tardive Dyskinesia Awareness Week by Advocating for Routine Screening and Monitoring
-
MFA Financial, Inc. Announces First Quarter 2024 Financial Results
-
Handel's Homemade Ice Cream Churns Up New Carrot Cake Flavor
-
Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow
-
Optery Named Winner by the 2024 Cybersecurity Excellence Awards for Attack Surface Management, Digital Footprint Management, and Employee Privacy Protection
-
Marizyme, Inc. Secures FDA 510(k) Clearance for Controlled Room Temperature Storage DuraGraft
-
SANDRIDGE ENERGY, INC. ANNOUNCES FIRST QUARTER 2024 OPERATIONAL AND FINANCIAL RESULTS RELEASE DATE AND CONFERENCE CALL INFORMATION
-
TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T Therapies
-
Hudson Technologies Enters Into Licensing Agreement With Chemours
-
Mobix Labs Enters into Global Distribution Agreement with Arrow Electronics
-
LSB Industries, Inc. Announces the Retirement of John Burns as Executive Vice President of Manufacturing and the Appointment of Scott Bemis as His Successor
-
The American Diabetes Association Announces New Diabetes Primary Care Alliance to Support Diabetes Care
-
KULR Technology Group Regains Compliance with NYSE American Continued Listing Standards
-
Alcoa President and Chief Executive Officer William Oplinger to Participate in BofA Securities 2024 Global Metals, Mining & Steel Conference
-
Myomo Announces First Lump Sum Reimbursements for MyoPros Delivered to Medicare Part B Beneficiaries Under New CMS Fees
-
Nayax to Exhibit its Leading Payment and Vending Management Technology at The NAMA Show 2024
-
Jared Talisman Joins Colbeck Capital as Managing Director and Head of Originations
-
Quantum Energy Corporation dba flooidCX Corp [OTC: FLCX] Executes Licensing Agreement in the Philippines
-
Howard Energy Partners Names Kasi McCormick as Senior Vice President of Organizational Effectiveness and Integration
-
Bayside Corporation Highlights Advancements and CEO Vision for Future Growth
-
SRIVARU (SVMH) Completes Production Model of PRANA 2.0
-
Odysight.ai Announces Appointment of Einav Brenner as Chief Financial Officer
-
Alarum to Release First Quarter 2024 Earnings on May 21, 2024
-
Ohmyhome Reports Robust Performance in the First Quarter of 2024, Anticipates Over 110% y-o-y Revenue Growth in First Half of the Year
-
Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update
-
MGP Names New Distilling Solutions Vice President
-
Latin Metals Receives Positive Results from Airborne Magnetic and Radiometric Survey, Organullo Project, Argentina
-
Blüm Holdings Inc. Acknowledges Impact to Cannabis Industry from DEA’s Plan to Reschedule Marijuana
-
AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen®
-
RESEARCH FRONTIERS TO HOST FIRST QUARTER 2024 CONFERENCE CALL
-
Antelope Enterprise Schedules Second Half and Fiscal Year End 2023 Earnings Conference Call
-
IREN to Release Third Quarter Results and Host Conference Call on May 15, 2024
-
April 2024 Monthly Investor Update
-
Sparket to Integrate Technology with AmTote
-
Fortrea Reschedules Release of First Quarter 2024 Financial Results and Conference Call
-
Hexaware Strengthens Data Capabilities with Acquisition of Softcrylic
-
Alat boosts sustainable manufacturing capabilities with the launch of Electrification and AI Infrastructure business
-
IB2 founder Girbal: "young managers, go for green !"
-
BRI Signals Strength: Launches Buyback Amidst Stock Price Corrections
-
Cohen & Company Reports First Quarter 2024 Financial Results
-
Capitalight Congratulates Railstate on Transaction
-
Lerman Law Firm Announces Fraud Investigation into George Leyva; Seeks Information from Victims and Witnesses Nationwide